PFENEX BIOPHARMACEUTICALS Trademark

Trademark Overview

On Wednesday, February 12, 2020, a trademark application was filed for PFENEX BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the PFENEX BIOPHARMACEUTICALS trademark a serial number of 88794485. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 4, 2022. This trademark is owned by Pfenex Inc.. The PFENEX BIOPHARMACEUTICALS trademark is filed in the Personal, Legal & Social Services category with the following description:

licensing of intellectual property
pfenex biopharmaceuticals

General Information

Serial Number88794485
Word MarkPFENEX BIOPHARMACEUTICALS
Filing DateWednesday, February 12, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements

Pseudo MarkPFENEX BIO PHARMACEUTICALS
Goods and Serviceslicensing of intellectual property
Disclaimer with Predetermined Text"BIOPHARMACEUTICALS"

Classification Information

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 4, 2020
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfenex Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePfenex Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, April 4, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 31, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 23, 2021ASSIGNED TO EXAMINER
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, June 2, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 2, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, June 2, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, November 19, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, November 19, 2020FINAL REFUSAL E-MAILED
Thursday, November 19, 2020FINAL REFUSAL WRITTEN
Wednesday, November 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 4, 2020NON-FINAL ACTION E-MAILED
Monday, May 4, 2020NON-FINAL ACTION WRITTEN
Friday, May 1, 2020ASSIGNED TO EXAMINER
Tuesday, February 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 15, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

biopharmaceuticals pfenex property intellectual licensing